Aim of this study was to genetically characterize two carbapenemase-producing Escherichia coli strains obtained from a pediatric patient affected by diarrhea, expressing OXA-181 and/or NDM-5 type enzymes. The above microorganisms were collected in the same Desenzano hospital (Northern Italy) where the bla NDM- 5 gene was detected for the first time in Italy 3 years ago. One strain (5P), belonged to sequence type ST405/ST477 (according to Pasture/Oxford schemes) and serotype O102:H6. It was characterized by a 130562 bp multi-replicon plasmid IncFII/IncFIA/IncFIB (pVSI_NDM-5) enclosing two main antibiotic resistance islands: (i) ARI-I, 10030 bp in size, carried genes coding for β-lactam- (bla OXA- 1, bla CTX-M- 15), fluoroquinolone/aminoglycoside- (aac(6')-lb-cr) and phenicol- resistance (catB3), (ii) ARI-II, 15326 bp in size, carried genes coding for sulfonamide- (sul1), β-lactam- (bla NDM- 5, bla TEM- 1 B), phenicol- (catB3), trimethoprim- (dfrA17), antiseptic- (qacEΔ1), and aminoglycoside- (aadA5, rmtB) resistance. The other isolate (5M), belonged to sequence type ST2659/ST759 and serotype O50/02:H18, and carried four plasmids: a 153866 bp multi-replicon IncFII/IncFIA/IncFIB (pISV_IncFII_NDM-5), an 89866 bp IncI1 plasmid, a 51480 bp IncX3 plasmid (pISV_IncX3_OXA181), and a 41143 bp IncI plasmid (pISV_IncI_CMY-42). pISV_IncFII_NDM-5 carried two main antibiotic resistance islands: (i) ARI-III, 12220 bp in size, carried genes coding for β-lactam- (bla OXA- 1), fluoroquinolone/aminoglycoside- (aac(6')-lb-cr), tetracycline- (tet(B)) and phenicol- resistance (catB3, catA1), and ii) ARI-IV, 26527 bp in size, carried determinants coding for macrolide- (erm(B), mph(A)), sulfonamide- (sul1), beta-lactam- (bla NDM- 5, bla TEM- 1 B), trimethoprim- (dfrA14, dfrA12), antiseptic- (qacEΔ1), and aminoglycoside- resistance (aadA5). pISV_IncI_CMY-42 harbored the bla CMY- 42 gene coding for beta-lactam resistance, pISV_IncX3_OXA181 harbored genes encoding fluoroquinolone- (qnrS1) and beta-lactams- resistance (bla OXA- 181). In conclusion, the detection of two different NDM-5 E. coli strains from a pediatric patient with a history of travel to the Far East countries strongly highlight an increasing trend and risk of importation from such areas.

Biomedical Center Faculty of Medicine in Pilsen Charles University Pilsen Czechia

Clinical Microbiology Laboratory AO Desenzano del Garda Brescia Italy

Department of Clinical Surgical Diagnostic and Pediatric Sciences Unit of Microbiology and Clinical Microbiology University of Pavia Pavia Italy

Department of Microbiology Faculty of Medicine in Pilsen University Hospital in Pilsen Charles University Pilsen Czechia

Zobrazit více v PubMed

Aung M. S., San N., Maw W. W., San T., Urushibara N., Kawaguchiya M., et al. (2018). Prevalence of extended-spectrum Beta-Lactamase and carbapenemase genes in clinical isolates of Escherichia coli in myanmar: dominance of blaNDM-5 and emergence of blaOXA-181. Microb. Drug Resist. 24 1333–1344. 10.1089/mdr.2017.0387 PubMed DOI

Baek J. Y., Cho S. Y., Kim S. H., Kang C.-I., Peck K. R., Song J.-H., et al. (2019). Plasmid analysis of Escherichia coli isolates from South Korea co-producing NDM-5 and OXA-181 carbapenemases. Plasmid 104:102417. 10.1016/j.plasmid.2019.102417 PubMed DOI

Balm M. N. D., Ngan G., Jureen R., Lin R. T. P., Teo J. W. P. (2013). OXA-181-producing Klebsiella pneumoniae establishing in Singapore. BMC Infect. Dis. 13:58. 10.1186/1471-2334-13-58 PubMed DOI PMC

Barton B., Harding G., Zuccarelli A. (1995). A general method for detecting and sizing large plasmids. Anal. Biochem. 226 235–240. 10.1006/abio.1995.1220 PubMed DOI

Bitar I., Dagher C., Salloum T., Araj G., Tokajian S. (2018). First report of an Escherichia coli from Lebanon carrying an OXA-181 carbapenemase resistance determinant. J. Glob. Antimicrob. Resist. 12 113–114. 10.1016/j.jgar.2018.01.002 PubMed DOI

Bitar I., Piazza A., Gaiarsa S., Villa L., Pedroni P., Oliva E., et al. (2017). ST405 NDM-5 producing Escherichia coli in Northern Italy: the first two clinical cases. Clin. Microbiol. Infect. 23 489–490. 10.1016/j.cmi.2017.01.020 PubMed DOI

Brettin T., Davis J. J., Disz T., Edwards R. A., Gerdes S., Olsen G. J., et al. (2015). RASTtk: a modular and extensible implementation of the RAST algorithm for building custom annotation pipelines and annotating batches of genomes. Sci. Rep. 5:8365. 10.1038/srep08365 PubMed DOI PMC

Camacho C., Coulouris G., Avagyan V., Ma N., Papadopoulos J., Bealer K., et al. (2009). BLAST+: architecture and applications. BMC Bioinform. 10:421. 10.1186/1471-2105-10-421 PubMed DOI PMC

Carattoli A., Zankari E., García-Fernández A., Larsen M. V., Lund O., Villa L., et al. (2014). In SilicoDetection and typing of plasmids using plasmidfinder and plasmid multilocus sequence typing. Antimicrob. Agents Chemother. 58 3895–3903. 10.1128/aac.02412-14 PubMed DOI PMC

Castanheira M., Deshpande L. M., Mathai D., Bell J. M., Jones R. N., Mendes R. E. (2010). Early dissemination of NDM-1- and OXA-181-producing Enterobacteriaceae in Indian hospitals: report from the SENTRY antimicrobial surveillance program, 2006-2007. Antimicrob. Agents Chemother. 55 1274–1278. 10.1128/aac.01497-1410 PubMed DOI PMC

Cho S. Y., Huh H. J., Baek J. Y., Chung N. Y., Ryu J. G., Ki C.-S., et al. (2015). Klebsiella pneumoniae Co-producing NDM-5 and OXA-181 Carbapenemases. South Korea. Emerg. Infect. Dis. 21 1088–1089. 10.3201/eid2106.150048 PubMed DOI PMC

Dagher T. N., Azar E., Al-Bayssari C., Chamieh A. S., Rolain J.-M. (2019). First detection of colistin-resistant Klebsiella pneumoniae in association with NDM-5 carbapenemase isolated from clinical lebanese patients. Microb. Drug Resist. 25 925–930. 10.1089/mdr.2018.0383 PubMed DOI

Djordjevic S. P., Roy Chowdhury P., McKinnon J. M., Liu M. Y. (2018). Multidrug resistant uropathogenic Escherichia coli ST405 with a novel, composite IS26 transposon in a unique chromosomal location. Front. Microbiol. 9:3212. 10.3389/fmicb.2018.03212 PubMed DOI PMC

Doi Y., Potoski B. A., Adams-Haduch J. M., Sidjabat H. E., Pasculle A. W., Paterson D. L. (2008). Simple disk-based method for detection of Klebsiella pneumoniae Carbapenemase-type -lactamase by use of a boronic acid compound. J. Clin. Microbiol. 46 4083–4086. 10.1128/jcm.01408-1408 PubMed DOI PMC

Glupczynski Y., Huang T.-D., Bouchahrouf W., Castro R. R. D., Bauraing C., Gérard M., et al. (2012). Rapid emergence and spread of OXA-48-producing carbapenem-resistant Enterobacteriaceae isolates in Belgian hospitals. Int. J. Antimicrob. Agents 39 168–172. 10.1016/j.ijantimicag.2011.10.005 PubMed DOI

Hoang C. Q., Nguyen H. D., Vu H. Q., Nguyen A. T., Pham B. T., Tran T. L., et al. (2019). Emergence of New Delhi Metallo-Beta-Lactamase (NDM) and Klebsiella pneumoniae Carbapenemase (KPC) Production by Escherichia coli and Klebsiella pneumoniae in Southern vietnam and appropriate methods of detection: a cross-sectional study. Biomed. Res. Int. 2019:9757625. 10.1155/2019/9757625 PubMed DOI PMC

Hornsey M., Phee L., Wareham D. W. (2011). A novel variant, NDM-5, of the New Delhi Metallo-β-Lactamase in a Multidrug-Resistant Escherichia coli ST648 isolate recovered from a patient in the United Kingdom. Antimicrob. Agents Chemother. 55 5952–5954. 10.1128/aac.05108-5111 PubMed DOI PMC

Jeon J., Lee J., Lee J., Park K., Karim A., Lee C.-R., et al. (2015). Structural basis for Carbapenem-hydrolyzing mechanisms of Carbapenemases conferring antibiotic resistance. Int. J. Mol. Sci. 16 9654–9692. 10.3390/ijms16059654 PubMed DOI PMC

Joensen K. G., Scheutz F., Lund O., Hasman H., Kaas R. S., Nielsen E. M., et al. (2014). Real-time whole-genome sequencing for routine typing, surveillance, and outbreak detection of verotoxigenic Escherichia coli. J. Clin. Microbiol. 52 1501–1510. 10.1128/jcm.03617-3613 PubMed DOI PMC

Kamjumphol W., Wongboot W., Suebwongsa N., Kluabwang P., Chantaroj S., Okada K. (2019). Draft genome sequence of a colistin-resistant Escherichia coli ST226: a clinical strain harbouring an mcr-1 variant. J. Glob. Antimicrob. Resist. 16 168–169. 10.1016/j.jgar.2019.01.009 PubMed DOI

Larsen M. V., Cosentino S., Rasmussen S., Friis C., Hasman H., Marvig R. L., et al. (2012). Multilocus sequence typing of total-genome-sequenced bacteria. J. Clin. Microbiol. 50 1355–1361. 10.1128/jcm.06094-6011 PubMed DOI PMC

Lee K., Lim Y. S., Yong D., Yum J. H., Chong Y. (2003). Evaluation of the hodge test and the imipenem-EDTA double-disk synergy test for differentiating Metallo- -Lactamase-producing isolates of Pseudomonas spp. and Acinetobacter spp. J. Clin. Microbiol. 41 4623–4629. 10.1128/jcm.41.10.4623-4629.2003 PubMed DOI PMC

Mairi A., Pantel A., Sotto A., Lavigne J.-P., Touati A. (2017). OXA-48-like carbapenemases producing Enterobacteriaceae in different niches. Eur. J. Clin. Microbiol. Infect. Dis. 37 587–604. 10.1007/s10096-017-3112-3117 PubMed DOI

Mediavilla J. R., Patrawalla A., Chen L., Chavda K. D., Mathema B., Vinnard C., et al. (2016). Colistin- and carbapenem-resistant Escherichia coli harboring mcr-1 and bla NDM-5, causing a complicated urinary tract infection in a patient from the United States. mBio 7:e001191-16 10.1128/mbio.01191-1116 PubMed DOI PMC

Monaco F., Mento G. D., Cuscino N., Conaldi P., Douradinha B. (2018). Infant colonisation with Escherichia coli and Klebsiella pneumoniae strains co-harbouring bla OXA-48 and bla NDM-1 carbapenemases genes: a case report. Int. J. Antimicrob. Agents 52 121–122. 10.1016/j.ijantimicag.2018.04.018 PubMed DOI

Nakano R., Nakano A., Hikosaka K., Kawakami S., Matsunaga N., Asahara M., et al. (2014). First Report of Metallo-β-Lactamase NDM-5-Producing Escherichia coli in Japan. Antimicrob. Agents Chemother. 58 7611–7612. 10.1128/aac.04265-4214 PubMed DOI PMC

Nordmann P., Poirel L., Walsh T. R., Livermore D. M. (2011). The emerging NDM carbapenemases. Trends Microbiol. 19 588–595. 10.1016/j.tim.2011.09.005 PubMed DOI

Ortega A., Sáez D., Bautista V., Fernández-Romero S., Lara N., Aracil B., et al. (2016). Carbapenemase-producing Escherichia coli is becoming more prevalent in Spain mainly because of the polyclonal dissemination of OXA-48. J. Antimicrob. Chemother. 71 2131–2138. 10.1093/jac/dkw148 PubMed DOI

Park M., Park S. D., Lee M. H., Kim S.-H., Lim K., Lee G., et al. (2016). The first report of NDM-5–producing uropathogenic Escherichia coli isolates in South Korea. Diagn. Microbiol. Infect. Dis. 85 198–199. 10.1016/j.diagmicrobio.2016.02.006 PubMed DOI

Paskova V., Medvecky M., Skalova A., Chudejova K., Bitar I., Jakubu V., et al. (2018). Characterization of NDM-encoding plasmids from Enterobacteriaceae recovered from czech hospitals. Front. Microbiol. 9:1549. 10.3389/fmicb.2018.01549 PubMed DOI PMC

Piazza A., Comandatore F., Romeri F., Pagani C., Floriano A. M., Ridolfo A., et al. (2018). First report of an ST410 OXA-181 and CTX-M-15 coproducing Escherichia coli clone in Italy: a whole-genome sequence characterization. Microb. Drug Resist. 24 1207–1209. 10.1089/mdr.2017.0366 PubMed DOI

Pitart C., Solé M., Roca I., Román A., Moreno A., Vila J., et al. (2015). Molecular characterization ofblaNDM-5carried on an IncFII plasmid in an Escherichia coli isolate from a nontraveler patient in Spain. Antimicrob. Agents Chemother. 59 659–662. 10.1128/aac.04040-4014 PubMed DOI PMC

Poirel L., Heritier C., Tolun V., Nordmann P. (2004). Emergence of oxacillinase-mediated resistance to imipenem in Klebsiella pneumoniae. Antimicrob. Agents Chemother. 48 15–22. 10.1128/aac.48.1.15-22.2004 PubMed DOI PMC

Poirel L., Potron A., Nordmann P. (2012). OXA-48-like carbapenemases: the phantom menace. J. Antimicrob. Chemother. 67 1597–1606. 10.1093/jac/dks121 PubMed DOI

Rojas L. J., Hujer A. M., Rudin S. D., Wright M. S., Domitrovic T. N., Marshall S. H., et al. (2017). NDM-5 and OXA-181 Beta-Lactamases, a significant threat continues to spread in the Americas. Antimicrob. Agents Chemother. 61:e00454-17. 10.1128/aac.00454-417 PubMed DOI PMC

Rotova V., Papagiannitsis C. C., Skalova A., Chudejova K., Hrabak J. (2017). Comparison of imipenem and meropenem antibiotics for the MALDI-TOF MS detection of carbapenemase activity. J. Microbiol. Methods 137 30–33. 10.1016/j.mimet.2017.04.003 PubMed DOI

Sassi A., Loucif L., Gupta S. K., Dekhil M., Chettibi H., Rolain J.-M. (2014). NDM-5 Carbapenemase-encoding gene in multidrug-resistant clinical isolates of Escherichia coli from Algeria. Antimicrob. Agents Chemother. 58 5606–5608. 10.1128/aac.02818-2813 PubMed DOI PMC

Shen Z., Hu Y., Sun Q., Hu F., Zhou H., Shu L., et al. (2018). Emerging carriage of NDM-5 and MCR-1 in Escherichia coli from healthy people in multiple regions in china: a cross sectional observational study. Clin. Med. 6 11–20. 10.1016/j.eclinm.2018.11.003 PubMed DOI PMC

Solgi H., Badmasti F., Aminzadeh Z., Giske C. G., Pourahmad M., Vaziri F., et al. (2017). Molecular characterization of intestinal carriage of carbapenem-resistant Enterobacteriaceae among inpatients at two Iranian university hospitals: first report of co-production of bla NDM-7 and bla OXA-48. Eur. J. Clin. Microbiol. Infect. Dis. 36 2127–2135. 10.1007/s10096-017-3035-3033 PubMed DOI

Sugawara Y., Akeda Y., Hagiya H., Sakamoto N., Takeuchi D., Shanmugakani R. K., et al. (2019). Spreading patterns of NDM-producing Enterobacteriaceae in clinical and environmental settings in yangon, Myanmar. Antimicrob. Agents Chemother. 63:e001924-18. 10.1128/aac.01924-1918 PubMed DOI PMC

Sugawara Y., Akeda Y., Sakamoto N., Takeuchi D., Motooka D., Nakamura S., et al. (2017). Genetic characterization of blaNDM-harboring plasmids in carbapenem-resistant Escherichia coli from Myanmar. PLoS One 12:e0189435. 10.1371/journal.pone.0184720 PubMed DOI PMC

Wu W., Feng Y., Tang G., Qiao F., Mcnally A., Zong Z. (2019). NDM Metallo-β-Lactamases and their bacterial producers in health care settings. Clin. Microbiol. Rev. 32:e00115-18 10.1128/CMR.00115-18 PubMed DOI PMC

Yaici L., Haenni M., Saras E., Boudehouche W., Touati A., Madec J.-Y. (2016). blaNDM-5-carrying IncX3 plasmid inEscherichia coliST1284 isolated from raw milk collected in a dairy farm in Algeria. J. Antimicrob. Chemother. 71 2671–2672. 10.1093/jac/dkw160 PubMed DOI

Yang Q., Fang L., Fu Y., Du X., Shen Y., Yu Y. (2015). Dissemination of NDM-1-producing Enterobacteriaceae mediated by the IncX3-Type Plasmid. PLoS One 10:e0129454. 10.1371/journal.pone.0129454 PubMed DOI PMC

Zankari E., Hasman H., Cosentino S., Vestergaard M., Rasmussen S., Lund O., et al. (2012). Identification of acquired antimicrobial resistance genes. J. Antimicrob. Chemother. 67 2640–2644. 10.1093/jac/dks261 PubMed DOI PMC

Preferred β-lactone synthesis can explain high rate of false-negative results in the detection of OXA-48-like carbapenemases

Genetic Plurality of OXA/NDM-Encoding Features Characterized From Enterobacterales Recovered From Czech Hospitals

Genomic Characterization of VIM and MCR Co-Producers: The First Two Clinical Cases, in Italy